EUROPEAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2020-12-29 12542404m56(暂无昵称)

投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！

173 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2021-12-29 小动量

每个期刊的格式要求一样么？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2020-12-03 独行er

审稿速度:1.0
偏重的研究方向：胃肠外科
经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊

141 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2020-05-18 Tgold

不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表:
我也是碰到这种情况请问仁兄后来怎么处理了

132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了

163 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2020-05-20 145a3c37m10暂无昵称

还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表::
不需要。Tgold 2020-05-18 00:00:00 发表:
不需要。

Tgold 2020-05-18 发表:: 不需要。

13 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2024-04-17 ms5000000719501821 来自上海

做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业

11 0

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2024-02-27 ms1000001401340130 来自湖北省

投稿第二天with editor，目前 8天了状态仍然没有变化

18 0

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-09-19 124d2c45m98暂无昵称

审稿速度如何

64 0

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-04-22 12282f4cm46(暂无昵称)

审稿速度:12.0 | 投稿命中率:25.0
经验分享：审稿真的非常慢

72 0

[GetPortalCommentsPageByObjectIdResponse(id=911969, encodeId=a1de911969c1, content=投了一篇letter，免疫治疗相关的irAE，2周左右一直显示submitted to journal，然后with editor又两周，然后decision in processing大约1周后直接接收了！效率挺高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e72551431, createdName=12542404m56(暂无昵称), createdTime=Tue Dec 29 21:20:59 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090220, encodeId=853f10902200d, content=每个期刊的格式要求一样么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904505, encodeId=00b590450565, content=审稿速度:1.0 偏重的研究方向：胃肠外科 经验分享：投稿5天给稿号，当天直接Decision in Process，是不是可以准备投下一个杂志了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Thu Dec 03 09:14:07 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591106, encodeId=7f815911067b, content=不需要。132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, beContent=132****8510暂无昵称 2020-05-15 00:00:00 发表: 我也是碰到这种情况请问仁兄后来怎么处理了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40244788005, createdName=Tgold, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591304, encodeId=941259130426, content=还有个小问题...EJC啥时候才会处理稿件...我已经投了快一周了还是submit to journalTgold 2020-05-18 发表:: 不需要。Tgold 2020-05-18 00:00:00 发表: 不需要。, beContent=Tgold 2020-05-18 发表:: 不需要。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/a1d7ad9c943d4c56bc1fdc26fb92c9a3/9d771ca88e414de6841b37fb91be1ab7.jpg, createdBy=a9db5076465, createdName=145a3c37m10暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-03-14 122220a4m01暂无昵称

偏重的研究方向：肿瘤
经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？

69 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务